Brief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
23/02/2024 22:38
Bellicum Pharmaceuticals Inc BLCM.PK :
* BELLICUM PHARMACEUTICALS- IN CONNECTION WITH DISSOLUTION
AND
PLAN OF DISSOLUTION, ON FEBRUARY 23, RICHARD A. FAIR RESIGNED AS
PRESIDENT AND CO'S CEO
Source text for Eikon: ID:n0001539497-24-000590
Further company coverage: BLCM.PK
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview